المؤلفون: Ramchandren, R, Johnson, P, Ghosh, N, Ruan, J, Ardeshna, KM, Johnson, R, Verhoef, G, Cunningham, D, de Vos, S, Kassam, S, Fayad, L, Radford, J, Bailly, S, Offner, F, Morgan, D, Munoz, J, Ping, J, Szafer-Glusman, E, Eckert, K, Neuenburg, JK, Goy, A

المساهمون: Cunningham, David

مصطلحات موضوعية: Diffuse large B-cell lymphoma, Ibrutinib, Lenalidomide, Rituximab

جغرافية الموضوع: England

وصف الملف: Electronic-eCollection; application/pdf

العلاقة: 101779; S2589-5370(22)00508-9; EClinicalMedicine, 2023, 56 pp. 101779 -; https://repository.icr.ac.uk/handle/internal/5751Test

الإتاحة: https://doi.org/10.1016/j.eclinm.2022.101779Test
https://repository.icr.ac.uk/handle/internal/5751Test

المؤلفون: Zinzani P. L., Ramchandren R., Santoro A., Paszkiewicz-Kozik E., Gasiorowski R., Johnson N. A., de Oliveira J. S. R., Buccheri V., Perini G. F., Dickinson M., McDonald A., Ozcan M., Sekiguchi N., Zhu Y., Raut M., Saretsky T. L., Nahar A., Kuruvilla J.

المساهمون: Zinzani P.L., Ramchandren R., Santoro A., Paszkiewicz-Kozik E., Gasiorowski R., Johnson N.A., de Oliveira J.S.R., Buccheri V., Perini G.F., Dickinson M., McDonald A., Ozcan M., Sekiguchi N., Zhu Y., Raut M., Saretsky T.L., Nahar A., Kuruvilla J.

مصطلحات موضوعية: Quality-of-life, pembrolizumab, brentuximab vedotin, relapsed/refractory, Hodgkin lymphoma

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34644372; info:eu-repo/semantics/altIdentifier/wos/WOS:000754639300004; volume:6; issue:2; firstpage:590; lastpage:599; numberofpages:10; journal:BLOOD ADVANCES; https://hdl.handle.net/11585/904791Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85123548552; https://ashpublications.org/bloodadvances/article/6/2/590/477276/Quality-of-life-analysis-of-pembrolizumab-vsTest

الإتاحة: https://doi.org/10.1182/bloodadvances.2021004970Test
https://hdl.handle.net/11585/904791Test
https://ashpublications.org/bloodadvances/article/6/2/590/477276/Quality-of-life-analysis-of-pembrolizumab-vsTest

المؤلفون: Zinzani, PL, Ramchandren, R, Santoro, A, Paszkiewicz-Kozik, E, Gasiorowski, R, Johnson, NA, de Oliveira, JSR, Buccheri, V, Perini, GF, Dickinson, M, McDonald, A, Ozcan, M, Sekiguchi, N, Zhu, Y, Raut, M, Saretsky, TL, Nahar, A, Kuruvilla, J

العلاقة: pii: 477276; Zinzani, P. L., Ramchandren, R., Santoro, A., Paszkiewicz-Kozik, E., Gasiorowski, R., Johnson, N. A., de Oliveira, J. S. R., Buccheri, V., Perini, G. F., Dickinson, M., McDonald, A., Ozcan, M., Sekiguchi, N., Zhu, Y., Raut, M., Saretsky, T. L., Nahar, A. & Kuruvilla, J. (2022). Quality-of-life analysis of pembrolizumab vs brentuximab vedotin for relapsed/refractory classical Hodgkin lymphoma. BLOOD ADVANCES, 6 (2), pp.590-599. https://doi.org/10.1182/bloodadvances.2021004970Test.; http://hdl.handle.net/11343/301626Test

الإتاحة: https://doi.org/10.1182/bloodadvances.2021004970Test
http://hdl.handle.net/11343/301626Test

المؤلفون: Lee, H., Flinn, I. W., Melear, J., Ramchandren, R., Friedman, J., Burke, J. M., Linhares, Y., Raval, M., Chintapatla, R., Feldman, T. A., Yimer, H., Islas-Ohlmayer, M., Dean, A., Rana, V., Gandhi, M. D., Renshaw, J., Gillespie-Twardy, A. L., Ho, L., Puhlmann, M., Guo, W., Yasenchak, C. A.

المصدر: HemaSphere ; volume 6, page 979-980 ; ISSN 2572-9241

الإتاحة: https://doi.org/10.1097/01.hs9.0000847224.76139.00Test

المؤلفون: Daver, N., Maris, M., Ramchandren, R., Bixby, D., Doucette, K., Mawad, R., Egan, D., Stevens, D., Zonder, J., Molloy, N., Scheuber, A., Bruns, I., Mantzaris, I., Konopleva, M., Goldberg, A. D.

المصدر: HemaSphere ; volume 6, page 1700-1701 ; ISSN 2572-9241

الإتاحة: https://doi.org/10.1097/01.hs9.0000850132.55221.5cTest

المؤلفون: Joffe, E., Nowakowski, G., Tun, H., Rosenthal, A., Lunning, M., Ramchandren, R., Li, C.-C., Zhou, L., Martinez, E., von Roemeling, R., Earhart, R., McMahon, M., Isufi, I., Leslie, L.

المصدر: HemaSphere ; volume 6, page 1011-1012 ; ISSN 2572-9241

الإتاحة: https://doi.org/10.1097/01.hs9.0000847352.16311.eaTest

المؤلفون: Hutchings, M., Ansell, S. M., Straus, D. J., Connors, J. M., Kim, W. S., Gallamini, A., Ramchandren, R., Friedberg, J. W., Advani, R., Evens, A. M., Smolewski, P., Savage, K. J., Bartlett, N. L., Eom, H.-S., Abramson, J. S., Dong, C., Campana, F., Fenton, K., Puhlmann, M., Radford, J.

المصدر: HemaSphere ; volume 6, page 101-102 ; ISSN 2572-9241

الإتاحة: https://doi.org/10.1097/01.hs9.0000843692.94815.d7Test

المؤلفون: Straus D. J., Dlugosz-Danecka M., Alekseev S., Illes A., Picardi M., Lech-Maranda E., Feldman T., Smolewski P., Savage K. J., Bartlett N. L., Walewski J., Ramchandren R., Zinzani P. L., Hutchings M., Connors J. M., Radford J., Munoz J., Kim W. S., Advani R., Ansell S. M., Younes A., Miao H., Liu R., Fenton K., Forero-Torres A., Gallamini A.

المساهمون: Straus, D. J., Dlugosz-Danecka, M., Alekseev, S., Illes, A., Picardi, M., Lech-Maranda, E., Feldman, T., Smolewski, P., Savage, K. J., Bartlett, N. L., Walewski, J., Ramchandren, R., Zinzani, P. L., Hutchings, M., Connors, J. M., Radford, J., Munoz, J., Kim, W. S., Advani, R., Ansell, S. M., Younes, A., Miao, H., Liu, R., Fenton, K., Forero-Torres, A., Gallamini, A.

مصطلحات موضوعية: Clinical Trials and Observation, Lymphoid Neoplasia, Adult, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocol, Bleomycin, Brentuximab Vedotin, Dacarbazine, Doxorubicin, Female, Follow-Up Studie, Hodgkin Disease, Human, Intention to Treat Analysi, Male, Middle Aged, Neoplasm Staging, Survival Analysi, Treatment Outcome, Vinblastine

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000523314100008; volume:135; issue:10; firstpage:735; lastpage:742; numberofpages:8; journal:BLOOD; http://hdl.handle.net/11588/823875Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85081944235

الإتاحة: https://doi.org/10.1182/BLOOD.2019003127Test
http://hdl.handle.net/11588/823875Test

المؤلفون: Wang, M, Ramchandren, R, Chen, R, Karlin, L, Chong, G, Jurczak, W, Wu, KL, Bishton, M, Collins, GP, Eliadis, P, Peyrade, F, Lee, Y, Eckert, K, Neuenburg, JK, Tam, CS

العلاقة: pii: 10.1186/s13045-021-01188-x; Wang, M., Ramchandren, R., Chen, R., Karlin, L., Chong, G., Jurczak, W., Wu, K. L., Bishton, M., Collins, G. P., Eliadis, P., Peyrade, F., Lee, Y., Eckert, K., Neuenburg, J. K. & Tam, C. S. (2021). Concurrent ibrutinib plus venetoclax in relapsed/refractory mantle cell lymphoma: the safety run-in of the phase 3 SYMPATICO study. JOURNAL OF HEMATOLOGY & ONCOLOGY, 14 (1), https://doi.org/10.1186/s13045-021-01188-xTest.; http://hdl.handle.net/11343/296557Test

الإتاحة: https://doi.org/10.1186/s13045-021-01188-xTest
http://hdl.handle.net/11343/296557Test

المؤلفون: Zinzani, P. L., Raut, M., Saretsky, T., Ramchandren, R., Santoro, A., Paszkiewicz‐Kozik, E., Gasiorowski, R., Johnson, N. A., de Oliveira, J. S. R., Buccheri, V., Perini, G. F., Dickinson, M., McDonald, A., Ozcan, M., Sekiguchi, N., Giezek, H., Nahar, A., Kuruvilla, J.

المصدر: Hematological Oncology ; volume 39, issue S2 ; ISSN 0278-0232 1099-1069

الإتاحة: https://doi.org/10.1002/hon.105_2880Test